N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA₂ DS₂ -VASc risk score for long-term cardiovascular events in acute coronary syndrome patients with atrial fibrillation.

ABSTRACT:

Background

It is important to identify patients with co-morbid acute coronary syndrome (ACS) and atrial fibrillation (AF) at high risk and adopt proper management strategies to improve their prognosis.

Hypothesis

The addition of N-terminal pro-B-type natriuretic peptide (NT-proBNP) could improve predictive value for long-term cardiovascular events beyond the CHA₂ DS₂ -VASc score in patients with co-morbid ACS and AF.

Methods

A total of 1223 patients with baseline NT-proBNP between January 2016 and December 2019 were included in the study. The primary endpoint was all-cause death at 12 months. The secondary outcomes included 12-month cardiac death and major adverse cardiovascular and cerebrovascular event (MACCE), defined as a composite of all-cau

SUBMITTER: Mu X 

PROVIDER: S-EPMC10352965 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature